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A PILOT STUDY OF THE IMPACT OF A PULMONARY CLINICAL DECISION UNIT ON
OUTCOMES IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Introduction
In today’s competitive environment, healthcare leaders are driven to reduce waste,
remove inefficiency, and eliminate unnecessary hospital readmissions in ordered to achieve goals
outlined in Section 3025 of the Affordable Care Act. Hospitalization accounts for nearly onethird of the total $2 trillion spent on healthcare in the United States (Locker, 2011). While some
readmissions are appropriate and unavoidable, a fragmented healthcare system and lack of care
coordination causes patients to be admitted back into the hospital. Rehospitalizations are
expensive, potentially harmful, and a sign of suboptimal care delivery.
Attention to this issue has intensified with a new Hospital Readmission Reduction
Program (HRRP), which penalizes hospitals for having high readmissions rates (Robert Wood
Johnson Foundation, 2013). Rates of patients readmitted within 30 day of discharge from the
hospital impact the HRRP defined by the Center for Medicare and Medical Services (CMS). The
HRRP is CMS’s most noteworthy regulatory program, with potential reductions in future
reimbursement according to performance relative to a baseline period. In 2013, penalties were
imposed up to 1%, with rates increasing per program mandates up to 3% in 2015. Performance at
or above national levels enables acute care facilities to retain the 3% at risk amount, while below
standard rates translate into decreased reimbursement (The CMS Blog, 2013).
Background and Significance
More than 2,000 hospitals across the United States were penalized by the government in
October 2013, because their patients were re-admitted back to the hospital within 30-day of
discharge. Together these hospitals will forfeit about $280 million in Medicare funding over the
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next 5 years. This represents a major paradigm shift in healthcare payment structure, in which a
new reimbursement structure is reliant on patient outcomes (Rau, 2012). The fee-for-service
system, as well as some capitation methods, offer few incentives for preventing readmissions
that result from poor outpatient care or complications related to an initial hospitalization. One in
twelve adults discharged from the hospital are readmitted within 30 days. The cycle of
readmissions added $16 billion to the cost of healthcare in the United States. Due to the
astronomical cost, the HRRP is a method designed to ensure hospitals are accountable to making
certain that systems and structures are in place to reduce unplanned readmissions. (Reid, 2012).
According to Jencks, Williams and colleagues (2009), 19.6% of the 11,855,702 Medicare
beneficiaries were rehospitalized within 30 days and 34% were rehospitalized within 90 days;
67.1% of patients who had been discharged with medical conditions and 51.5% of those who
had been discharged after surgical procedures were rehospitalized or died within the first year
after discharge (Jencks, Williams, & Coleman, 2009). Among patients who were rehospitalized within 30 days after a surgical discharge, 70.5% were rehospitalized for a medical
condition. About 10% of rehospitalizations were likely to have been planned. The average
length of stay of rehospitalized patients was 0.6 days longer than that of patients in the same
diagnosis-related group (DRG) whose most recent hospitalization had been at least 6 months
previously (Jencks et al., 2009). The study provided supporting evidence that rehospitalization
among Medicare beneficiaries is widespread and costly.
Re-admissions are measured by a ratio, dividing a hospital’s number of “predicted”
30-day re-admission diagnoses by the number that would be expected. Ratio is a comparison
of the average re-admission rates with other hospitals with similar patients. The HRRP
policies currently apply to patients who meet the operational definition for 30-day re-
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admission for diagnoses of Acute Myocardial Infarction (AMI), Heart Failure (HF) and
Pneumonia (PN) ("Re-admission Reduction Program," 2013). However, in Fiscal year 2015,
the HRRP expanded the list of patient types to include Chronic Obstructive Pulmonary
Disease (COPD), Coronary Artery Bypass Grafts (CABG), Percutaneous Transluminal
Coronary Angioplasty (PTCA), Stroke, other vascular surgical procedures (The CMS
Blog, 2013).
Over 5% of all deaths and one in eight admissions from the emergency department are
patients with COPD. In the state of Kentucky, more than 9% of the population has a diagnosis
of COPD according to the 2013 Behavioral Risk Factor Surveillance System Survey (Center for
Disease Control and Prevention, 2012). According to the data specific to COPD 30-day hospital
readmission rates for Norton Audubon Hospital, the baseline in 2013 was 18.4%.
It is predicted that COPD will move from the 12th leading cause of disability to the 5th
place by the year 2020 (Sridhar, Dawson, Roberts & Partridge, 2008). COPD is one of the most
common medical conditions associated with re-admissions. Two targeted strategies being used to
improve readmission rates of patient with COPD are the development of Observation Units and
admission of patients classified as observation status. Observation Units, also known as Clinical
Decision Units (CDU) and or Short Stay Units (SSU), are designed for patients whose clinical
conditions are unclear and for whom additional evaluation is needed in order to make a clinical
decision to admit the patient to inpatient. The names used to identify observation location are
interchangeable: CDU, OU, and SSU. These locations where patients are managed, utilize the
same principal for providing care to patient between 8 – 24 hours. Services provided to patients
in observation areas are typically protocol driven interventions to determine appropriate
monitoring, diagnostic testing, assessment of clinical symptoms, laboratory testing, and response
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to treatment in order to determine whether a patient requires additional treatment or if the patient
is to be admitted as an inpatient.
Furthermore, the quality of life for patients with COPD is often compromised due to the
course of the disease. COPD impairs the quality of life, by preventing people with this condition
from socializing and enjoying life and hobbies they love. Patients with COPD experience limited
energy levels and may feel frustrated and angry about an inability to do what they want to do in
life (Zamzam, Azab, Wahsh, Ragab & Allam, 2012). Anxiety and depression are frequently
associated with diseases which further contribute to rehospitalization. When patients with COPD
are admitted to the hospital, condition treatment and medication adjustment are the primary goals
of getting the patient well enough for discharge. Unfortunately healthcare many opportunities for
addressing underlying issues that contribute to unplanned readmissions. Hospitalized patients and
/or their families often receive limited education about self-care and the prevention of unplanned
readmissions. There is no formal hand-off to post-acute care providers, nor are socioeconomic
factors impacting the disease discussed with the patient. When subsequent exacerbation arises,
the emergency room is the typical solution (Graf et al., 2012).
Acute Exacerbation of Chronic Obstructive Pulmonary Disease (AECOPD) represents a
major burden to the healthcare system. A study by Reid (2012) reported that the cost of
readmission increased to $97 billion annually when including patients readmitted within one
year. Patients with COPD are frequently readmitted due to the growing numbers of comorbidities and mortalities associated with the disease. These patients utilize an enormous
amount of healthcare resources.
Diez and colleagues (2008) evaluated social determinates and predictors of the cost of care
associated with COPD patients in primary care and acute care settings. The authors identified
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that the largest component of cost associated with the treatment and management of COPD
occurred during hospitalization. On average, the total cost per COPD patient admitted to an
acute care facility was $1,922.72 + $2,306.44. The cost varied according to the admission status.
Patients, assigned to an observation status, spend less time in the hospital than patients assigned
to an inpatient status. Patient status ensures the avoidance or abuse of the hospital system by not
admitting patients who are not "sick" enough to require an inpatient stay. Observation status is
defined by CMS as the utilization of a bed for periodic patient monitoring to evaluate the
patient’s condition in order to determine the need for an inpatient admission (Diez et al., 2008).
Hospitals are capitalizing on this distinction through the introduction of observation units
(OUS). When patients are classified as status observation, and /or are admitted to an OU, the
billing is different than an inpatient admission. Observation status is reimbursed according to
the Outpatient Prospective Payment System. Observation is an alternative to inpatient
admissions since it enables the provider the opportunity to determine if an admission is
necessary (Schmidt & Schmidt, 2014). When patients are discharged from an observation area,
the time spent in observation status does not count as an inpatient admission; thereby, OUs and
observation status affect hospital readmission rates. OUs enable the provider to determine if the
patients’ condition warrants medical necessity for an inpatient and has been frequently used
with cardiac patients. However, the effectiveness of this approach with COPD has not been
thoroughly evaluated.
Purpose Statement
The purpose of this retrospective study was to analyze the impact of a pulmonary clinical
decision unit (PCDU) on patient outcomes related to COPD. At Norton Audubon Hospital
(NAH), patients with COPD who were not ready for discharge from the emergency department
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(ED) and who did not meet inpatient criteria were admitted to the hospital as observation status
to a PCDU during the time period from January 28, 2014 - August 31, 2014. The PCDU staff
provided expedited evaluation and utilized protocols to provide therapeutic interventions and
coordinated services in order to discharge patients home or to determine the need for an
inpatient admission. The study will measure the impact of cohorting patients with COPD in a
PCDU on the cost of care, 30-day hospital readmission rates, and subsequent emergency
department visits within 7 days of discharge
Literature Review
An integrative review was performed on evidence-based literature relating to use of
OUs. The following databases were searched from the years 2004 to present: CINAHL,
PubMED, Medline and Cochrane database Systemic Reviews. Key words used in the
database were: Patient Protection Affordable Care Act, hospital re-hospitalization,
preventable COPD re-admissions, and COPD cost of care, clinical decision unit, short stay
unit and observation units. The search was limited to human adults over 18 years from 2004
to 2014. Inclusion criteria included a focus on high risk readmissions, clinical decision units,
CMS criteria for admission as compared to observation status, ED visits for COPD, and COPD
readmission strategies. Out of 150 citations reviewed, 15 studies met the inclusion criteria.
The use of Observation Units (OUs), is gaining popularity as a strategy for decreasing
emergency department crowding, reducing hospital admissions and lowering costs. According
to Suri (2011), observation units (OUs) first became popular after the paradigm shift from feefor-service to value-based purchasing. The purpose of the OU within the structure of an
Accountable Care Organization (ACO), to increase healthcare systems’ accountability by
developing and implementing strategies to improve patient outcomes while also lowering
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healthcare costs. ACOs achieve cost savings by reducing avoidable admissions, preventing
unplanned readmissions, and decreasing ED visits. Delivering healthcare services while
offering hospitals financial incentives are the governing principles associated with an ACO
model. Challenges confronted by hospitals in terms of controlling cost, decreasing crowded
emergency departments , and improving outcomes for patients support the business case for
implementing observation units or CDUs. (Suri, 2011).
Decker and colleagues (2008) performed a prospective, randomized trial of an emergency
department observation unit (EDOU) for acute onset of atrial fibrillation. The purpose of the
study was to investigate an EDOU protocol for managing acute onset of atrial fibrillation and to
compare the treatment of EDOU patients to those under usual hospital admission management.
The study was done over 3 years (September 1999- December 2002) in the EDOU of a tertiary
referral center. The EDOU utilized protocols to manage patients admitted to the area. At the end
of the 39 month study period, 85% of EDOU patients were converted to Sinus rhythm versus
73% in the routine care group (difference 12%; CI -1% to 25%; P < .06). The mean LOS was
10.1 versus 25.2 hours, (difference 15.1 hours; 95% CI 11.2 to 19.6; P <.001) for EDOU and in
hospital respectively. Nine EDOU patients required inpatient admission. Eleven percent of
EDOU group had recurrence of Atrial fibrillation during follow-up versus 10% of the routine
inpatient care group (difference 1%; 95% CI -9% to 11%; P < .93) (Decker, et al 2008,). In
summary, the EDOU integrated protocols to control heart rate and cardiovert patients when
necessary. The length of stay in the EDOU was significantly better in these patients when
compared to those under routine care.
The majority of CDU research has been conducted on patients with HF. Because the
population is living longer, HF is mostly observed in the elderly population. Due to the
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prevalence of HF, more studies have been conducted with this population. The diagnosis of HF
is the most expensive diagnosis for Medicare healthcare systems exceeding $34.8 billion in 2005
(Linden & Milstein, 2008.). Unfortunately, frequently reoccurring symptoms of HF result in
multiple ED visits which are followed by multiple readmissions. Heart Failure is a disease that is
characterized by frequent visits to the ED due to the steady deterioration of the patients’ clinical
presentation and patterns. As the disease progresses, the quality of life is negatively affected over
time.
Peacock and colleagues (2006) reviewed innovative options for managing
decompensated heart failure in an EDOU. EDOU protocol driven patient management was
integral to the success of the unit. In a pre and post study of 154 decompensated HF EDOU
patients, the investigators demonstrated that protocol-driven EDOU treatment of decompensated
HF is an effective and safe method to manage patients and to decrease inpatient admissions. The
ED revisit rate decreased by 56% (0.90- 0.51; P < 0.000) during the 90-day follow-up period.
Another statistically significant outcome from the study demonstrated a reduction in 90-day
inpatient readmission rate of 64% (0.77 – 0.50; P < 0.007). Finally, 90-day mortality and ED
readmission decreased from 4% to 1% (P= .096). A structured outpatient EDOU management
protocol positively decreases 90-day rates of emergency department revisit rate and decreases
inpatient hospitalizations (Peacock, 2005).
Another study examined optimizing patient care in an OU to decrease HF readmission
rates (Peacock, 2005). Patients received specialized treatment plans in the cardiac OU for acute
decompensated HF. The OU provided an alternative strategy to lowering hospital readmissions
rates. Entry to the OU was determined by a set of criteria and treatment protocols once the
patient was admitted to the OU. To determine appropriate patient placement to an observation
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unit for heart failure, the following information was collected while the patients were in the
emergency department: the medical history and physical, chest x-ray, measurement of B-type
natriuretic peptide (BNP), ECG and cardiac markers. According to the results, the investigators
concluded that the implementation of an observation unit with patient specific protocols and
standing orders for decompensated HF was associated with a 56% reduction in the 90-day HF
emergency department revisit rate (P <.0001) and a reduction in the 90-HF Rehospitalization
rate (P=.007). Additional benefits associated with the observation units were a reduction in
90-day mortality rate from 4% to 1% (P < .096) (Peacock et al., 2006).
Proactive evaluation and effective management of HF in an OU, prevents unforeseen
complications associated with decompensated heart failure. Aggressive patient management,
education and follow-up discharge planning supports the business case for implementing an OU
as a component of patient care. Jagminas and colleague (2004) examined the optimal location for
an OU. A retrospective study was conducted for the purpose of comparing the utilization of an
EDOU, to an in hospital observation unit (IHOU) for chest pain in the same acute care facility.
There were 440, or 36.9% of 1190 patients, with chest pain presenting to the ED over a 5 month
period who were admitted to the EDOU, while the IHOU admitted, 973 or 69.3% of 1404
patients from the ED. There were fewer patients with chest pain who were converted to an
inpatient status from the EDOU, 35 patients or 7.9% of 440 (P < 0.000), when compared with
the IHOU, n = 187(19.2%) or 973; (P <.001). The average cost of care for each EDOU patient
was $889.87 (95% CI 862.8 – 916.9) as compared to $1,039.70 (95% CI 991.7 – 1087.7) for
each IHOU patients (Jagminas & Partridge, 2005). According to the findings, the cost of care
was higher when patients were in the IHOU as compared with the EDOU for managing low-risk
to moderate risk patients with chest pain. In summary, observation units have proven to reduce
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inpatient admissions, decrease emergency room crowding and control cost (Suri, 2011).
Furthermore, the cost of care for managing low-risk patients with disease specific protocols in an
OU is an efficient method for managing patients (Jagminas & Partridge, 2004).
When considering a location for an observation unit and the strength of evidence for
managing patients in an EDOU, the majority of studies were conducted on patients with
decompensated HF. A structured protocol- driven EDOU for the treatment of decompensated HF
has been proven to be an effective and safe method to managing patients and decreasing
inpatient admissions (Peacock, 2005). There is a growing body of evidence in support of
observation units for managing patients with HF. Observation units that implemented decision
trees according to 3 process maps to differentiate patients at low, intermediate and high risk of in
hospital mortality, provided guidance for providers and structure to ensure that the patient’s
condition meets the criteria for admission to an observation unit (Peacock et al. 2006).
The goal of observation status and the utilization of OUs to decrease cost by creating
incentives for efficient, effective healthcare. Healthcare is making positive gains to limit cost by
proactively preventing complications and avoidable days in the hospital. Studies support
observation medicine by cohorting specific patient types to an observation unit or clinical
decision unit. Due to the growing number of patients diagnosed with COPD, cohorting patients
and using protocol driven order sets, enables physicians to spend more time to stabilize the
patient and to determine medical necessity (Decramer & Wim, 2013). The protocol driven care
for COPD is based on the Gold recommendations (Vestbo, et al. 2013). Regardless of where
OUs are within the hospital environment, the evidence supports deploying and executing
resources to ensure these specialty areas are equipped and staffed with qualified healthcare
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workers. OUs contribute to improved care, and to control the cost of healthcare for vulnerable
patient population.
Methods
Development of Interventions
An innovative approach to preventing unplanned admissions, reduce cost, and reduce
ED visits between admissions is to apply a data-driven, quality strategy to improve patient
outcomes. The design and implementation of the PCDU at NAH followed the DMAIC model
(Define, Measure, Analyze, Improve and Control). DMAIC is a subcomponent of Six Sigma
Performance Improvement Methodology. The fundamental objective of Six Sigma
methodology is to implement evidence-based strategies by means of focusing on process
improvement and eliminating variations (Six Sigma, 2009).
The Six Sigma DMAIC is performance improvement methodology consisting of five
phases. During the Define phase, the executive leadership team at Norton Audubon Hospital
(NAH) identified that COPD 30-day hospital readmission rates were higher than the national
average. The United States average 30-day hospital readmission rate for Medicare patients with
a diagnosis of COPD is 18.0 % (Agency for Healthcare Research and Quality, 2013). NAH
readmission baseline rate for COPD was 18.4% in 2013. The length of stay for patients with
COPD is 4.52 days and cost of care is $2,966 per patient. These factors associated with
managing COPD led to the development of a committee to address these issues.
In the define phase, the champion for the project contacted the lead investigator and
requested assistance in leading a committee to address COPD outcomes. The lead investigator
and the project sponsor, created a multidisciplinary team to develop processes and to
implement evidence based strategies to improve outcomes for patients with COPD. To make
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certain that the committee members accurately represented the healthcare team, an in-depth
analysis was completed to determine which internal and external stakeholders affect the
process. The stakeholders were identified as representatives from nursing, information
services, pulmonologists, pastoral care, respiratory care and care management. The team
created a charter, which defined the scope of the project, as well as identified how the problem
affects the patient and the organization (see Appendix A). Due to the shift in hospital
payment and more focus on value, the committee validated that patients with a diagnosis of
COPD are at the greatest risk for readmissions due to the number of co-morbidities associated
with the disease. The scope of this project was specific to patients admitted and discharged
with a primary diagnosis of COPD.
The Measure phase involved gathering information on the physical characteristics
accompanying COPD and the current situation in order to provide an understanding of the
improvement efforts. This phase was crucial in understanding current performance and
processes impacting readmissions and the cost of care. The data were abstracted from the
electronic medical records to determine the demographics related to patients with COPD; age,
discharge disposition and gender (see Appendix B). Additional data, measuring the cost of care,
length of stay, Emergency Department visits within 7 days and 30 day readmission rates were
used to determine the financial impact of COPD (see Appendix C).
During the Analyze phase, the team identified root causes of variations and gaps in care
affecting clinical outcomes associated with COPD. Variations identified by the team consisted
of inconsistent utilization of outdated protocols, lack of a mechanism for identifying patients at
risk for readmissions, inconsistent education provided to staff regarding pulmonary disease
management, absence of or no pulmonary physician consulted on the case, patients admitted to
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different nursing units, and patients with no medical home or primary care physician. In the
Improve phase, the team developed the future state map, goals and researched best practice for
managing AECOPD. According to the evidence, hospitals that admitted patient with
AECOPD to an OU had a reduction in 30-day hospital readmission rates and cost of care
(Decramer & Wim, 2013). During this phase, the project sponsor collaborated with the chief
finance officer, the chief nursing officers and Pulmonologists to develop a business plan which
included timelines for opening a PCDU for patients who were assigned an observation status with
pulmonary disease. The clinical experts on the committee developed the protocols associated
with the PCDU (see appendix D). The focus on multidimensional care which was patientcentered, safe, cost-effective, efficient, evidence based and culturally competent was the
foundation supporting the PCDU. The PCDU was located on 4 east nursing area. The unit was a
23-hour observation unit specifically designed for patient with pulmonary diagnoses. The PCDU
had 8 observation beds which allowed patients to be assessed using evidence-based strategies
with optimal resource utilization. Optimal care of patients with diagnoses of COPD was the goal
of staff members who worked in the PCDU.
The staff were provided with in-depth education which was specific for the management of
COPD. The education materials were created using the COPD “Gold Standards” as the best
practice for managing COPD (Vestbo, et al. 2013). COPD protocols were created by the clinical
leadership team representing the PCDU. Based on the evidence, the education provided to the
staff covered the following areas; medication use, recognition and management of chronic
obstructive pulmonary disease exacerbation symptoms, lab values, bronchial hygiene, oxygen
modalities, breath sounds, smoking cessation, and advance directives. The care of the patient
with COPD is very challenging and complex. The comprehensive education and training
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provided to the staff was an essential component to providing an infrastructure within the PCDU
to ensure that the staff working in the PCDU were consciously and clinically competent.

The

PCDU opened January 27, 2014. Patients admitted to the observation unit were required to meet
the following criteria:


High likelihood of correction to baseline status within 48 hours.



Acceptable vital signs: blood pressure. >100/60, respiratory rate < 28, pulse < 120.



Pulse oximetry 90% or higher on room air, correctible to > 90% on oxygen, on < 50%
FiO2.



No sign or symptoms of fatigue or impending fatigue



Alert and without any medical status changes



Chest X-Ray without an apparent acute process.

Once patients were admitted to the PCDU, the protocol order set was initiated. If the patient
did not have a pulmonologist, an automatic referral was sent to the pulmonary specialists. While
in the PCDU, all patients with COPD were seen during multidisciplinary rounding. Patients are
provided with the COPD education folder, which includes the booklet “Learning to Live with
COPD”. The booklets were given to the patient upon initial diagnosis and available for reference
upon subsequent admissions. Patient education was progressive while in the PCDU.
Information taught to the patient and/or family members consisted of, living in a smoke free
environment, medication compliance, maintaining comfortable breathing by using directives (
e.g. pursed-lip breathing technique, forward body positions), managing stress, preventing and
treating COPD exacerbation, maintaining an active life style and healthy diet. While in the
PCDU, the nursing staff discussed the benefits associated with pulmonary rehabilitation as an
opportunity for successful long-term COPD management. Once the patient was stable and in
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agreement with the transitional plan for pulmonary rehabilitation, a referral was sent to the
department. The nursing staff in the PCDU were responsible for scheduling a follow-up
appointment with the patients’ primary care physician prior to discharge. These strategies
ensured that those patients were able to manage their disease once discharged from the hospital.
Another component to the Improve phase consisted of leveraging available technology to
identify patients at risk for readmission. Predictive analytics were embedded into the PCDU
clinical work flow. A predictive analytic tool was built into the electronic health record. Epic
Readmission Manager (RAM) was a health intelligence platform which proactively identifies
patients at risk for hospital readmissions. The strategy for preventing unplanned readmissions
by using Epic RAM, in conjunction with admitting patients with Acute Exacerbation Chronic
Obstructive Pulmonary Disease (AECOPD) to the PCDU. Epic RAM forecasts the probability of
a patient being readmitted. The forecast was based on the number of prior emergency
department visits within the past 6 months, the time since the last discharge, the name of the
primary care physician, age, living arrangements, and the ability to perform activities of daily
living, residence type and reliable transportation. These markers are included in Epic RAM
readmission predictive index (PI). This score was used to risk stratify patients and to identify
patients who require advanced discharge planning or additional care transitional services to
prevent an unplanned readmission. The Care Manager assigned to the PCDU would track and
monitor PI scores of 6 or greater. A PI score of 6 or greater is an alert to the care manager to
further evaluate the patient by using the Risk Readmission Assessment tool in Epic (see
appendix E).
The final phase is Control. Control involves making certain the improvement strategies were
hardwired into the culture (Six Sigma, 2009). The Control phase involves creating a process
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control plan and to sustain the improvements. Developing and implementing evidence-based
strategies for improving outcomes for patients with a diagnoses of COPD is a priority within
Norton Healthcare (NHC). The evidence supports hospital environments that embraced OUs as a
means of managing patients with chronic disease.
Evaluation Plan
Sample criteria were analyzed and evaluation has been completed for patients treated
during the time period from January 28 – August 31, 2014 with the following diagnostic
related groups (DRGs) and International Statistical Classification of Disease ICD codes (ICD9 codes) for COPD: 190, Chronic Pulmonary COPD WMCC, 191, Chronic Obstructive
Pulmonary Disease, W CCMS and 192, Chronic Obstructive Pulmonary Disease
W/OCC/MCC MS (Schmidt & Schmidt, 2014). Additional data analysis were completed with
patients who were admits to the PCDU as observations according to ICD-9 codes (See
appendix F for CMS reimbursement rates for COPD). These codes are based on disease types
and are utilized by healthcare settings in the United States and many other parts of the world
(Mitus, 2008). ICD 9 codes are a common language that is used for understanding outpatient
diagnoses the same way. ICD 9 codes for COPD observation are as follow 491.21, Chronic
obstructive asthma with status asthmatic, 491.22, Chronic Obstructive Asthma, with Acute
exacerbation, 491.9, Unspecific Chronic Bronchitis and 492.8, other emphysema. ICD-9 codes
are assigned to patients who are admitted as observation.
Design
The study was a pilot of a retrospective study of data on patients admitted with COPD
exacerbations to two different hospital settings within NHC. Norton Audubon Hospital
(NAH) is a 432-bed acute care hospital specializing in cardiac, cancer, surgical, pulmonary,
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neurology, and orthopedic, vascular, emergency and diagnostic care. The treatment group
involved patients admitted as observation NAH on 4 East and 4 West. Patients who are
assigned to an observation status primary diagnosis are based International Classification of
Disease, Ninth Revision.
The other acute care facility included in the study is Norton Hospital (NH) a licensed
642-bed hospital with particular emphasis on advanced diagnostic and surgical procedures.
NH served as the comparison facility. The hospital is a teaching facility for the University
of Louisville School of Medicine. Norton Hospital’s patients with COPD are the comparison
group in the study. According to availability of beds in Norton Hospital, patients with COPD
are admitted to different medical-surgical units.
Data Collection Plan
The data collection plan consisted of the following data elements for patients admitted as
observation for COPD: the facility, admitting unit, discharge unit, discharge disposition,
primary diagnosis, hospital status, co-morbidities, and length of stay in hours, age, and gender,
charges per case, direct variable cost, observation hours and Pulmonologist on case. The
evaluation of the outcome indicators will measure hours in observation, COPD 30-day
readmission rates ED, 7day ED readmissions, variable cost per case and charges (see the
Appendix G).
The primary outcomes associated with the proposal are: Thirty day readmission rates, the
cost of care and ED 7 day readmission. The operational definitions for the financial variable
associated with the cost of care are: charges- a price for services render while in the hospital, and
variable cost- includes the cost for medications and supplies (Modern Healthcare, 2012). The
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project timelines illustrates the road map for completing the requirements associated with the
capstone project (see Appendix H).
Required Approval
The approval of the System Vice President of Medical Affairs and Care Continuum, The
University of Louisville Institutional Review Board (IRB) office, and Norton Healthcare Office
of Research Administration was received. The waiver was the required documentation for
approval for evaluating the pilot project (see Appendix I).
Ethical Consideration
Permission to conduct the study was obtained according to policies outlined in the
Institutional Review Board at Bellarmine University and Norton Healthcare. The analysis of
existing data qualified this study for an exempt status. The project was retrospective analysis
based on data retrieved from the electronic medical record. Confidentiality was maintained by
using the medical record number. The data were password protected and kept on a personal
computer in a locked office at NHC.
Data Analysis
Descriptive statistics were used to determine the characteristics of age, gender, discharge
disposition, payer source, attending physician and secondary comorbidities. The Mann-Whitney
U test was used to determine statistically significant difference in charges, variable cost and
hours in observation between the control group and the intervention group. The Mann-Whitney
U test is a nonparametric analysis that statistically verifies the likelihood that two independent
groups have been taken from the same population. The Mann-Whitney U test is based on the
comparison of each observation from the control group with each observation from the
intervention group (Plichta & Garon, 2009). In other words, the Mann-Whitney test enables the
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researcher to observe and compare difference between the performance of the control group and
the intervention group.
Results
Pilot Characteristics
The pilot consisted of twenty-seven patients. Eight patients were in the intervention
group and nineteen patients were in the control group. In the study, females with COPD
diagnosis were more likely to be admitted to an observation status. Medicare and Kentucky
Exchange were the major payer source and the majority of attending physicians overseeing the
care of these patients were internal medicine specialists. Internal medicine specialists at NAH
and NH are hospitalists employed by NHC. All patients in the study were discharged from
observation status to home. Both groups had patients with secondary diagnoses including atrial
fibrillation, acute or chronic renal failure, and diabetes accompanied by a primary diagnoses of
COPD (Table 1).
Table 1. Characteristics difference between the control group and intervention group
Mean (SD)

Age

Control Group
( N = 19)
62 (SD= 12.25)

Intervention Group
(N = 8)
61 (SD = 13.57)

Gender
Male
Female

8 (42%)
11(58%)

4 (50%)
4 (50 %)

Medicare
Kentucky Exchange
Humana
United Healthcare
Private

7 (37.%)
8 (42%)
1 (3.7%)
1 (3.7%)
1 (3.7%)

4 (50%)
3 (37.5%)
1 (12.5%)

19 (100%)

8 (100%)

Payer

Discharge disposition
Home
Attending Physician
Pulmonologists

1 (5.2%)
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Internal Medicine
Family Medicine
Infectious Disease
Intervention
Cardiology

12(63%)
4 (21%)
1 (5.2%)
1 (5.2%)

8 (100%)

Comorbidity
Atrial Fibrillation
1 (12.5%)
Tobacco Use Disorder
2 (10.52%)
Iron Deficiency
1 (12.5%)
Diabetes
1 (5.26%)
Hypertension
4 (21%)
History of Tobacco Use
Acute Respiratory
1 (5.26%)
Failure
Acute and Chronic
1(5.26%)
Respiratory Failure
Shortness of Breath
1(5.26%)
Long Term Use Meds
1(5.26%)
Coronary Artery Disease
Chest Pain
2 (10.52%)
Chronic Asthma
Chronic Pulmonary Heart Disease 2 (10.52%)
Convulsion Necrosis
Pneumonia Organism
1(5.26%)
Hypothyroidism
1 (5.26%)

1 (12.5%)
1 (12.5%)
1 (12.5%)
1(12.5%)

2 (25%)
1 (12.5%)
1 (12.5%)

Observation Hours
Hours in observation for the control group, ranged from 22 hours to 96 hours with a mean
of 38.47(SD = 20.01). The intervention hours in observation ranged from 16 hours to 48 hours
with a mean of 34.50 (SD =13.42) The mean rank represents observation hours per patient while
in observation status with COPD. The control groups (Mdn = 14.05) did not differ significantly
from the intervention group (Mdn = 13.88, U = 75, z = 0.0265, p = 0.38). Observation hours were
about the same in both hospitals over the same period of time. (Table 2).
Table 2. Observation hour for the control group and intervention group
Mean(SD)
Control Group

Mean Rank

Intervention Group

( N = 19)

(N = 8)

z

P

14.05

13.88

0.027

0.38

ns*
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Observation hours

38.47(SD = 20.01)

34.50 (SD = 13.42)

*ns = not statistically significant
Charge Results
Financial analyses were performed to compare the cost associated with charges acquired
while in observation. Charges were calculated utilizing the cost per day of caring for a patient in
observation. Charges in the control group ranged from $7,012 to $24,853 a mean of $13,437 (SD
=5,133) The intervention group charges ranged from $7,462 to $15,510 with a mean $10,265(SD
= 2,982) The mean rank represent charges per patient while in observation status with COPD.
The control groups (Mdn = 15.47.) did not differ significantly from the intervention group (Mdn
= 10.5), U = 48 , z = 1.4602 , p = 0.1443. Charges were calculated utilizing the cost per day of
caring for a patient in observation. (Table 3)
Table 3. Charge results comparing the control group and intervention group
Mean(SD)
Control Group

Intervention Group

( N = 19)

(N = 8)

Mean Rank

15.47

10.5

Charges

$13,437 (SD= 5,133)

z
1.4602

P
0.1443

ns*

$10,265 (SD = 2,982)

*ns = not statistically significant
Direct Variable Cost
Direct variable cost while in observation in the control group ranged from $627 to
$3,444 with a mean of $1,306 (SD = 655) The intervention group variable cost ranged from
$216 to $1,125 with a mean $725 (SD =303 ) The mean rank represents charges per patient while
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in observation status with COPD. The control groups (Mdn = 16.58) differ significantly from the
intervention group (Mdn = 7.88 , U = 27 , z = 2.5753 , p = 0.00988. The PCDU provided a site to
cohort patients with COPD which has demonstrated a significant reduction in direct variable
cost. (Table 4)
Table 4. Direct variable cost comparing the two groups
Mean(SD)

Mean Rank

Control Group
( N = 19)
16.58

Intervention Group
(N = 8)
7.88

Direct variable cost $1,306(SD = 655)

z
2.5753

P
0.00988

s*

$725 (SD = 303)

*s = statistical significant

Readmission Outcomes
Evaluation of readmission data relating to the control group and the intervention group
was conducted to compare the difference between 7-day ED readmission and 30-day
readmission percentages. The data indicated that there are variations among the two groups
when comparing readmission rates (Table 5).
Table 5. Readmission Percentages
Percentage
Control Group

Intervention Group

( N = 19)

(N = 8)

7- day ED readmission

0

1 (12.5%)

30-day readmission

1 ( 5.2%)

0

Discussion and Conclusion
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The primary objective of this quality improvement pilot was to determine if the PCDU
reduced COPD 7-day and 30-day readmissions rates, lowered direct variable cost and decreased
charges occurred while in the hospital. The capstone pilot was conducted on a small group of
patients who were admitted to observation status with a diagnosis of COPD. Research in the
development and use of observation units is still early in its adoption and implementation.
Multiple studies have demonstrated the clinical effectiveness of care delivery in specialty
observation units (Suri, 2011). In the intervention group, patients were admitted in observation
status to the 4th floor at Norton Audubon Hospital. The patients in this group were managed
using protocols and order sets that were evidence based using the GOLD Standard for COPD as
cited in Decramer & Wim, 2013. The control group consisted of patients admitted to Norton
Hospital under observation status. The patients were not limited to any specific units, and there
was no standardization in treatment. The findings are not surprising due to the length of the pilot
and the sample size.
Comparison of the outcomes of readmission between the two groups did not reveal any
trends. There was one 7-day readmission in the intervention group and no readmission at 30
days. The control group had no 7-day readmission and one readmission in 30 days. However,
there was a statistically significant difference in direct cost, with a lower cost in the control
group ($10,265 vs. $13,437; p=0.000988). A longer period of evaluating the effectiveness of the
PCDU would be ideal in order to determine the potential long term impact of the unit.
Healthcare organizations are creating observation beds within ED’s or within a nursing
unit. During the pilot, the location of the PCDU was on the fourth floor of Norton Audubon
Hospital . The PCDU was created by converting 8 existing beds on a 36-bed medical surgical
unit. The conversion of the observation beds decreased inpatient bed capacity on that unit to 28
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inpatient beds. Therefore, in the pilot, the analysis does not consider the startup cost associated
with the PCDU.
The average daily patient census for the PCDU was 4 patients per day which converts
into 50% unused capacity. At the same time with the escalating patient census associated with
the Kentucky Exchange insurance program, inpatient volume increased by 20%. Due to the
influx of patients from the ED requiring inpatient beds, the unused beds in the PCDU were
frequently assigned to other admission status. Keeping in perspective, the PCDU was
designed to admit pulmonary observation patients to the area. The influx of patients with
different admission status and diagnosis types to the PCDU, was a primary factor that
contributed to converting the PCDU beds back to medical-surgical beds.
Another crucial factor that contributed to the conversion of the PCDU back to medicalsurgical beds was a lack of physician support. Physicians refused to admit patients to the
PCDU due to personal preference and their lack of confidence with the PCDU staff’s ability to
provide care. Resources allocated to staff the PCDU were much lower as compared to acute
care or an inpatient bed. The staffing in the PCDU was 1:5 nurse patient ratio. Staffing in
medical-surgical units in the same hospital were 1:4 nurse patient ratio. A supportive
leadership team and a systematic approach intended for the treatment of AECOPD are
necessary in order for the PCDU to have remained open (Jagminas & Partridge, 2004) . Lack
of physician support to admit patients to the PCDU is a major concern for future endeavors
Limitations
There were several limitations associated with this pilot. The optimal metric for
determining the success of observation units is by measuring readmission rates. The literature
supports observation units, not only to determine medical necessities, but also to reduce costs
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associated with unplanned readmissions of patients with chronic disease (Ringquist, 2014).
About $25 billion dollars each year is spent on 30-day hospital readmission for patients with
chronic disease in United States (Robert Wood Johnson Foundation, 2013). Impacting
readmission rates is a complex endeavor which requires healthcare organizations to create
systems and structures to ensure that patients are able to manage their disease once they are
discharged from the hospital. The operational definition for determining 30-day hospital
readmissions defined by CMS does not include race, socioeconomics or noncompliance. Further
research is necessary to address healthcare equity, language barriers, health literacy, social
determinates and noncompliance in order to provide patients with the tool and resources to help
manage their disease (Billings et al., 2012). Therefore, this should be an area of critical
importance for future studies that will share the results of multiple organizations and the
utilization of observation units to lower readmission rates.
The second limitation associated with the pilot is being able to control COPD
observations of patients admitted to other nursing units within NAH. Although patients with
AECOPD were admitted to the PCDU, the feasibility of replicating this strategy in another
NHC facility is unknown.
Because the study was a retrospective evaluation, the third limitation of the pilot was
the functionality of the EMR predictive model. Unplanned hospital admissions in the current
EMR are not identified according to patients with the diagnosis of COPD. In order to determine
if the readmission was planned or unplanned, the physician must document the reason for
readmission in the EMR. Risk factors built in the EMR are generalized to the entire patient
population. The current version of the EMR prediction model does not have the capability of
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pulling data across multiple encounters. Therefore, the current readmission indicators within
the model are very limited and without the evidence to support the validity of the model.
Finally, there is no method for determining the severity of illness when patients are
assigned to observation due to the fact that patients in observation status are billed using
outpatient codes. Each code is assigned a dollar amount which translates to the cost of care.
When calculating the cost of care, claims data according to outpatient codes are collected by
payment and not by research. Methods for determining the cost of care are dependent on
accurately coding the information documented in the chart for reimbursement.
Recommendations
Recommendations for bringing observation units into practice have many implications.
The literature supports that using standardized practices can result in improved outcomes by
reducing avoidable readmissions, and reducing direct variable cost (Decker et al., 2008). The
intervention analyzed in the pilot used a standardized process and did show a reduction in direct
variable cost. Prior to the implementation of the PCDU, there was no contingency plans to
address the issues of potential low patient census in the unit. The business decision to pilot the
PCDU was based on historical volumes of an average daily census of 7 patients per day who were
in observation for COPD at Norton Audubon Hospital . Therefore, according to the
data, the assumptions were that the volumes would support the PCDU. Additional studies with
attention to developing stronger physician acceptance and process improvement holds
opportunities. Without the support from non-hospital employed Pulmonologists, the survival of
the PCDU was a constant threat. Finally staffing was a major concern to physicians who sent their
patients to the PCDU. Additional research is required in this area in order to ensure safe patient
nurse ratios are in alignment with the evidence.
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NAH successfully developed a clinical decision unit specifically for cardiovascular
disease. Lessons learned from that experience were that the unit was closed, with admission
only by a cardiologist, and there were well developed processes driven by protocols and order
sets. Consideration of establishing a unit with a narrowly defined focus on COPD appears to
have potential benefits in reducing costs and outcomes. The standardization of the process
should involve the engagement of the physicians coordinating care, and would require a close
relationship and communication among hospitalists and pulmonary specialists to develop the
protocols and details of order sets to maximize return of adequate pulmonary function. The
process would have to be designed to rapidly identify patients that would benefit from acute
inpatient treatment. By having a standard approach, the training and focus of the nursing staff
will improve the competencies of managing a complex set of patients. Coordinating care in this
way encourages improved communication between physicians, nurses and patients, and
subsequently reduce unnecessary and costly admissions.
Conclusion
The Affordable Care Act has transformed our nation’s healthcare system and
reimbursement structure. The shift in payment structures to improve quality, lower cost and to
create a culture of sustainable outcomes has created urgency in today’s healthcare
environment. Technology is an important aspect of care coordination across the continuum for
patients with chronic disease. In 2016, NHC is implementing an evidence-based predictive
model in the EMR. Having a well-established electronic medical record with the capacity to
drive analytics to determine contributing factors associated with hospital readmission is crucial
in healthcare. Strategies to reduce hospital re-admissions are targeting high-risk patients.
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Reducing the number of patients who are readmitted to the hospital with COPD is a
priority within NHC. Hospitals must make certain that systems and structures are in place to
ensure that patients receive the right level of care at the right time and right place. Diagnosis
specific observation units are an innovative approach for providing an alternative level of care in
which patients could benefit from an extended observation period. Studies have shown that OUs
reduce re-admission rates, control cost, reduce the LOS, and impact the utilization of ED visits
(Suri, 2011). Further research is recommended to identify other deliberate practices that can
contribute to better outcomes.
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Appendix A. Capstone Charter
Program Sponsor
Business Owner
Start/Target Date
Project Description

Jo Ellen Carpenter, DNP, Performance
Shirl Johnson
Chief Nursing Officer
Improvement Leader
Amanda Newman
September 21, 2013
March 31, 2014
Project End Date:
At the present time, patients typically placed under observation status are not placed in
one geographic location. These patients are mixed with inpatients, throughout the
nursing units. Due to this, the nursing staff is focused on inpatient care and may not be
accustomed to the pace and urgency necessary to move observation patients quickly.
The healthcare space is undergoing significant financial and clinical disruption.
As a result of these changes, NHC must improve processes associated with the clinical
management of patients with Chronic Disease. The scope of this project is specific to
patients admitted and discharged with a diagnosis of Chronic Obstructive Pulmonary
Disease, COPD. Cost per case for treating COPD is higher as compare to national
benchmarks. COPD. COPD patients also have a high readmission rate. This team will
develop processes and tools to assist in cohorting patients, keeping patients out of the
hospital and streamline orders set by identifying best practice for managing patients with
COPD.

Project Scope

The project extends to patients that present in the Emergency Department and do not
require patient admission but do not meet criteria to be discharged and can benefit from
further observation. Select direct admit patients that meet admission criteria may also be
serviced in the Clinical Decision Unit.

Goal (what will success look
like?):






Metric

Transition the placement of patients typically placed as observation from being
distributed throughout the hospital to a dedicated location.
Utilize criteria for admission and discharge of the patients served in the unit.
Prioritize the workload by focusing on targeted patient populations being managed
through other clinical effectiveness initiatives creating the opportunity to maximize
outcomes.
Maximize clinical outcomes by implementing evidence based protocols and order
sets, reduce length of stay, visits to the Emergency Department patients and decrease
readmission rates.

Metric (Decrease in):
1. Overall cost per case and other major cost drivers
2. Overall LOS
3. 31 day readmission rates (proper disease management function would focus and
understand readmission failures)
4. ED visits between admission

Business Results

Benefit to Customers

In October 2012, the center of Medicare and Medicaid will financially penalty acute care
facilities for patients readmitted within 30 days for any reason. Norton Healthcare needs
to develop processes that will decrease readmissions and decrease the cost of care per
case yet maintain or improve the quality of that care.
Patients are cohorted to one area
Patients do not return to the hospital.
Physicians will know their cost of care.
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Appendix B: Chronic Obstructive Pulmonary Disease Report Demographics
N= 692
Gender
Female
Male
Discharge disposition
Home, self-care
Expired
Skilled Nursing Facility
Hospice
Home Health Services
Discharge/ transferred to rehab
facility
Against medical advice
No.

Average Age
65.45
No. Discharges
476
216
No. Discharges
536
3
61
7
73
7

Std deviation
11.83
Percentage
68.8%
31.2%
Percentage
77.5%
0.4%
8.8%
1.0%
10.5%
1.0%

5
692

0.7%
100%
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Appendix C. Measure Phase, Chronic Obstructive Pulmonary Disease Report-(DRG, 190,191
and 192)
Measure

Average

Direct variable Cost
Length of Stay

$ 2,966
4.52
Rate

Any ED 7 days readmission
Any reason 30 day readmission

3.1%
18.4%

Std
deviation
$2,294
2.87

No. Discharges

No.
Readmits
21

No. Discharges

692
692

684
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Appendix D***Clinical Decision Unit Physician Orders for COPD and Asthma Exacerbation
Admission
NOTE: Check boxes below to initiate order
Date:
Time:
Place for observation
Service Level:
Admitting Physician:
Anticipated length of stay:
Anticipated post discharge needs:
Bed request comment:
Adult Code Status (Single Response)
{}Full Code
{}Allow a natural death (DNR)
{}Adult DNR with comfort measure panel
POC
{}POCT blood glucose monitor
Routine, 4 times daily before
meals
a
and at bedtime
{}POCT blood glucose monitor
Routine, Once for 0 ,,,,
,
occurrence
{}POCT blood glucose monitor
Routine, every 6 hours
Laboratory
{}CBC w/Diff
0400 for 1 o e
occurrence
{} Blood Gas , Arterial
{}NT-ProBNP
{}Basic Metabolic Panel (BMP)
0
o
{}HCG, Qualitative
o
t
{}Comprehensive Metabolic Panel (CMP)
o
t
Radiology
{} XR Chest 2 VW
.
e
I
W
r

Routine, Morning draw at
o
Routine, Once
Routine, Once
Routine, Morning draw at
0400 for 1 occurrence
STAT , once for 1
occurrence, if not done in
the ED
STAT , once for 1
occurrence, if not done in
to the ED
Routine1 time imaging for 1 o
occurrence Reason for exam:
COPD/Asthma.
Is patient pregnant?
What is the patient’s sedation
requirement?
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Appendix D (continues)***Clinical Decision Unit Physician Orders for COPD and Asthma
Exacerbation Admission
NOTE: Check boxes below to initiate order
CT
{} CT Chest wo contrast
o
0
W
r

Routine 1 time imaging for 1 reason for
for exam: COPD or Asthma
Is patient pregnant?
What is the patient’s sedation
requirement?

{} CT Chest wo & w contrast
o
0
W
r

Routine 1 time imaging for 1 reason for
for exam: COPD or Asthma
Is patient pregnant?
What is the patient’s sedation
requirement?

Cardiac Status
ECG
{}EKG 12 lead
Routine, Once
Q
Consult/Referring Cardiologist:
A
Family Physician:
R
Reason for exam: COPD/Asthma
VTE Prophylaxis and Core Measure
Mechanical Device, Medication and Contradictions
All adult IP admission must be evaluated for VTE prophylaxis within 4 hours of admission.
At least one of the following orders must be selected for these patients
NOTE: If VTE screening score is greater than 1, please order mechanical compression device to
comply with Core Measure requirements.
{}Place mechanical compression device
Routine every 12 hours
.
Mechanical Compression Device: Calf length
{} Fondaparinux (Arixtra) injection
2.5 mg, Subcutaneous, every 24 hours
.
Routine
{} Enoxaparin (Lovenox) syringe
40 mg, subcutaneous, every 24 hours
.
Routine
{}Low risk- no VTE prophylaxis needed
{}INR greater than 3- no VTE prophylaxis needed
{}Patient refused VTE prophylaxis
{}Patient is possible risk for VTE but there is a contraindication to Mechanical and
medication VTE prophylaxis - Admission
{} Contraindication for Mechanical VTE
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Appendix D (continues) ***Clinical Decision Unit Physician Orders for COPD and Asthma
Exacerbation Admission
NOTE: Check boxes below to initiate order
Antibiotics
{} Azithromycin (Zithromax) : 500mg oral, daily ,routine
{} Doxycycline (Vibramycin) : 100mg, oral 2 times daily, routine
Beta-2 Agonist
{} Ipratropium-Albuterol Minineb& treatment and linked panel
{} Albuterol-Ipratropium (Duo-neb) 0.5 – 2.5 mg/dl nebulizer
4 hours (RT)
{} Nebulizer Treatment routine , every 4 hours (RT)
{} Ipratropium-Albuterol Minineb & treatment And Linked Panel
{} Albuterol-Ipratropium (Duo-neb) 0.5 – 2.5 mg/dl nebulizer
..
e
{} Nebulizer Treatment
(RT)
Corticosteroids ( Single Response)
{} Methyl Prednisolone Sodium Succinate) Solumedrol
Every 8 hours
.
Injection, Routine
{}Methylprednisolone sodium succinate (Solumedrol)
,

Nebulization, every.

.

Routine
Nebulization, every 2.
hours (RT)
Shortness of Air. Routine
Routine, every 2 hours. .
60 mg, Intravenous,
40 mg, Intravenous
Every 8 hours
Injection, Routine
20 mg, Intravenous,
Every 8 hours
Injection, Routine
40 mg, oral, daily with
breakfast

{} Methyl Prednisolone Sodium Succinate )Solumedrol
,
,
{} Methylprednisolone sodium succinate (Solumedrol)
.
Leukotriene Receptor Antagonists
{}Montelukast (Singular) tablet
10 mg, Oral, Nightly,
,
Routine
Stress Ulcer Prophylaxis (Single Response)
{}Pantoprazole (Protonix) EC table
40 mg, Oral, Nightly,,
,
Routine
{} Famotidine (Pepcid) tablet
20 mg, Oral, 2 times
,
daily , Routine
Other
{}Nicotine (Nicoderm C Q) 21 mg/24hr 1 patch, Transdermal, daily, starting
today at 9:00 AM
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Appendix E. Epic RAM work flow
Epic RAM: PROCESS FLOW FOR HIGH RISK PATIENTS
Patient

Physician

Nurse

Care Manager

Other Disciplines
(ad hoc)

Patient admit

Readmission Score in Epic (RAM) RAM score appear in the patient header
Classification (6-13) Red/High Risk
(3 -5 ) Yellow/ Moderate Risk
(0-2 ) white/ Low Risk
All disciplines are able to review contributing factors associated with the score

yes
Patient @ Risk
for readmission
yes/no

no

end

Patient Family
Education:
Teach back

Physician
Team Work

Nurse and Care Manager identifies
contributing factors associated with the
readmission

Nurse
completes
admission
assessment
which
includes

Care Managers
interviews
patients using
risk
assessment
tool (ver. 2)

Nurse Interviews
pts to gather
additional
information ( 30day readmission
question
embedded within
assessment

Evaluate
reasons for risk

Consultations
according to
pt. needs

Rapid Round: multidisciplinary: Rounding by exception
(Readmission score, identification of risk factors allowing
providers to targeted interventions to reduce potentially
avoidable readmission)
Teach back:
APRN/CNS/
Nurses
Care coordination: Robust discharge planning, drivers of
discharge disposition, transitions of care

Disposition

AVS to include discharge plan to mitigate rehospitalization:
Coordination of information across the continuum
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Appendix F. Medicare Diagnoses Related Group Reimbursement Benchmarks for COPD

The National average payment for DRG is calculated by multiplying the current weight of the
DRG by the national average hospital Medicare base rate. The national average hospital
Medicare rate is the average of the full up to date labor related and non-labor related amount
published in the Federal Register, FY 2015, and Final Rule. This information is provided as a
benchmark reference only. There is no official publication of the average hospital base rate:
therefore, the national average payments provided in this table are approximated (Schmidt &
Schmidt, 2014, p. 588).
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Appendix G. Outcome Measurements
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Appendix H: Program Study Timeline: A Pilot Study of a Pulmonary Clinical Decision Unit on Outcomes in Patients with Chronic
Obstructive Pulmonary Disease

41

Appendix I:
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